✦ LIBER ✦

Low doses of mycophenolate mofetil with low doses of tacrolimus prevent acute rejection and long-term function loss after lung transplantation

✍ Scribed by M.W Gerbase; A Spiliopoulos; M Fathi; L.P Nicod

Book ID: 117230934
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 87 KB
Volume: 33
Category: Article
ISSN: 0041-1345
DOI: 10.1016/s0041-1345(01)01978-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A “Steroid-Free” Tacrolimus and Low-Dose

A “Steroid-Free” Tacrolimus and Low-Dose Mycophenolate Mofetil Primary Immunosuppression Does Not Prevent Early Acute Rejection After Liver Transplantation

✍ P. Reggiani; M. Arru; M. Regazzi; S. Gatti; M.D. Molinaro; L. Caccamo; U. Maggi; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 80 KB

Regimen of Tacrolimus-Based Immunosuppre

Regimen of Tacrolimus-Based Immunosuppression With Basiliximab, Mycophenolate Mofetil, and Low-Dose Steroid Reduces Acute Rejection in Kidney Transplants

✍ K. Hoshinaga; A. Aikawa; M. Murai; H. Yamamoto; N. Hirayama; S. Shishido; A. Has 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Two Doses of Daclizumab in Conjunction w

Two Doses of Daclizumab in Conjunction with Low-Dose Cyclosporine, Mycophenolate Mofetil and Steroids Resulted in a Low Incidence of Acute Rejection after Renal Transplantation

✍ H. Ekberg; N. H. Persson; R. Källen; N. Gül-Baykurt 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

Basiliximab and Mycophenolate Mofetil in

Basiliximab and Mycophenolate Mofetil in Combination With Low-Dose Cyclosporine and Methylprednisolone Effectively Prevent Acute Rejection in Kidney Transplant Recipients

✍ D. Kovac; V. Kotnik; A. Kandus 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 74 KB

Evaluation of renal function in liver tr

Evaluation of renal function in liver transplant recipients receiving daclizumab (Zenapax), mycophenolate mofetil, and a delayed, low-dose tacrolimus regimen vs. a standard-dose tacrolimus and mycophenolate mofetil regimen: A multicenter randomized clinical trial

✍ Eric M. Yoshida; Paul J. Marotta; Paul D. Greig; Norman M. Kneteman; Denis Marle 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

Posttransplant chronic renal failure, secondary to calcineurin inhibitor agents, is emerging as a major problem in liver transplantation. We report a randomized clinical trial comparing daclizumab, delayed low-dose tacrolimus (target trough level 4-8 ng/mL, starting day 4-6), Investigational Arm (n

Chronic cyclosporine-induced nephrotoxic

Chronic cyclosporine-induced nephrotoxiciy in heart transplant patients: Long-term benefits of treatment with mycophenolate mofetil and low-dose cyclosporine

✍ V. Sanchez; J.F. Delgado; J.M. Morales; R. Tello; M.A. Gómez; P. Escribano; A.G. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 85 KB